4-(Phthalimido)-Cyclohexanone

We are 4-(Phthalimido)-Cyclohexanone CAS:104618-32-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  4-(Phthalimido)-Cyclohexanone
CAS.NO:  104618-32-8
Synonyms:
4-Phthalimidocyclohexanone
2-(4-oxocyclohexyl)isoindole-1,3-dione
N-(4-Oxocyclohexyl)phthalimide
2-(4-Oxocyclohexyl)isoindoline-1,3-dione

Molecular Formula: C14H13NO3
Molecular Weight:  243.25800

Physical and Chemical Properties:
Density: 1.357 g/cm3
Boiling point: 409.96ºC at 760 mmHg
Melting point: /
Flash point:191.1±19.1 °C
Refractive index: 1.627

Specification:
Appearance:  White off-white powder
Purity:≥98%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Pramipexole CAS:104632-26-0
Intermediates of Pramipexole dihydrochloride CAS:104632-25-9

4-(Phthalimido)-Cyclohexanone


Related News: Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.183438-24-6 Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.8-cloro-1-octanol CAS:23144-52-7 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.(2S)-1-N-(2-aminoethyl)-3-(4-ethoxyphenyl)propane-1,2-diamine,trihydrochloride Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).

Related Products
Product Name
Chloroiodomethane View Details
(Benzotriazol-1-Yloxy)Dipyrrolidinocarbenium Hexafluorophosphate View Details
tert-Butylisocyanate View Details
2-Fluoro-6-hydroxybenzoic acid manufacturer acetone oxime manufacturer L-Anserine nitrate manufacturer 3-Methyl-1-(4-sulfophenyl)-2-pyrazolin-5-one manufacturer 3,5-Difluoropyridine-4-carboxylic acid manufacturer